ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Levine Leaves Presidency Of Rockefeller University.

February 15, 2002

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

May 9, 2008

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

January 26, 2007

Rays Of Hope Candlelight Vigil Scheduled For Oct. 6.

September 8, 2000

Congress Orders Programs In Nutrition Research; Cancer Act Extension Beefs Up NCI Chief’s Authority

July 12, 1974

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012